These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 10582201)

  • 21. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
    Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
    J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study.
    Troise C; Voltolini S; Canessa A; Pecora S; Negrini AC
    J Investig Allergol Clin Immunol; 1995; 5(1):25-30. PubMed ID: 7551201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.
    Vourdas D; Syrigou E; Potamianou P; Carat F; Batard T; André C; Papageorgiou PS
    Allergy; 1998 Jul; 53(7):662-72. PubMed ID: 9700035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal Phleum pratense allergoid immunotherapy. Double-blind, randomized, placebo-controlled trial.
    Sola Martínez FJ; Barranco Jiménez RM; Martín García C; Senent Sánchez C; Blanco Guerra C; Fernández-Rivas M; Vega Castro A; Dávila González I; Carbonell Martínez A; Panizo Bravo C; Gómez Torrijos E; Rodríguez Gil D; Palacios Peláez R
    Clin Exp Allergy; 2020 Dec; 50(12):1352-1361. PubMed ID: 32946612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensitive monoclonal antibody-based enzyme-linked immunosorbent assay to quantify Parietaria judaica major allergens, Par j 1 and Par j 2.
    Arilla MC; González-Rioja R; Ibarrola I; Mir A; Monteseirín J; Conde J; Martínez A; Asturias JA
    Clin Exp Allergy; 2006 Jan; 36(1):87-93. PubMed ID: 16393270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.
    Purello-D'Ambrosio F; Gangemi S; Isola S; La Motta N; Puccinelli P; Parmiani S; Savi E; Ricciardi L
    Allergy; 1999 Sep; 54(9):968-73. PubMed ID: 10505460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
    Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S
    J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
    Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
    Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
    Pfaar O; van Twuijver E; Hecker H; Boot JD; van Ree R; Klimek L
    Int Arch Allergy Immunol; 2013; 160(4):420-4. PubMed ID: 23183541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a Par j 1/Par j 2 mutant hybrid with reduced allergenicity for immunotherapy of Parietaria allergy.
    Bonura A; Passantino R; Costa MA; Montana G; Melis M; Bondì ML; Butteroni C; Barletta B; Corinti S; Di Felice G; Colombo P
    Clin Exp Allergy; 2012 Mar; 42(3):471-80. PubMed ID: 22356145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
    Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
    Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability and positive efficacy results after subcutaneous immunotherapy with Parietaria judaica depot extract.
    Enrique E; de Rojas DH; Alba P; Flores I; Colomer N; Andreu C; Gómez-Fernández MC; Landeta A; Asturias JA; Martínez A; Madariaga-Goirigolzarri B
    Immunotherapy; 2018 Oct; 10(14):1253-1263. PubMed ID: 30326788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of allergen specific immunotherapy (IT) on natural killer cell activity (NK), IgE, IFN-gamma levels and clinical response in patients with allergic rhinitis and asthma.
    Sin B; Misirligil Z; Aybay C; Gürbüz L; Imir T
    J Investig Allergol Clin Immunol; 1996; 6(6):341-7. PubMed ID: 9015776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K; van der Werf JF; Boot D; van Ree R
    Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinations of Par j 1 by a competitive enzyme immunoassay using human specific IgE and IgG. Validation by skin prick testing.
    Boluda L; Casanovas M; Prieto JL; Fernández-Caldas E
    J Investig Allergol Clin Immunol; 1998; 8(4):207-13. PubMed ID: 9777534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.